Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (1061-1070 of 1,161) with videos related to

Pageof 117
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal TumorPing Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.
JCO Precision Oncology|June 1, 2023
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch SyndromeMegha Ranganathan, Rosalba E Sacca, Magan Trottier, et al.
JCO Precision Oncology|April 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal AdenocarcinomaSamuel L Cytryn, Raktim Borpatragohain, Karmelina Charalambous, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Nature Communications|March 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancersEzra Y Rosen, Helen H Won, Youyun Zheng, et al.
Cancer Cell|April 21, 2023
Genomic mapping of metastatic organotropism in lung adenocarcinomaHarry B Lengel, Brooke Mastrogiacomo, James G Connolly, et al.
Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.
JCO Precision Oncology|November 9, 2020
Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis PairsMichael L Cheng, Mark T A Donoghue, François Audenet, et al.
Pageof 117

Showing results (1061-1070 of 1,161) with videos related to

Sort By:
Pageof 117
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal TumorPing Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.
JCO Precision Oncology|June 1, 2023
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch SyndromeMegha Ranganathan, Rosalba E Sacca, Magan Trottier, et al.
JCO Precision Oncology|April 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal AdenocarcinomaSamuel L Cytryn, Raktim Borpatragohain, Karmelina Charalambous, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Nature Communications|March 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancersEzra Y Rosen, Helen H Won, Youyun Zheng, et al.
Cancer Cell|April 21, 2023
Genomic mapping of metastatic organotropism in lung adenocarcinomaHarry B Lengel, Brooke Mastrogiacomo, James G Connolly, et al.
Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.
JCO Precision Oncology|November 9, 2020
Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis PairsMichael L Cheng, Mark T A Donoghue, François Audenet, et al.
Pageof 117